Serum levels of CRP and NT-proBNP have shown to predict adverse outcomes in patients with HF, both in HF with reduced ejection fraction (HFrEF, LVEF <50%) and in HF with preserved ejection fraction (HFpEF, LVEF >50%). The gene discussed is NPPB; the disease is hydrops fetalis.